Castle Biosciences, Inc. (CSTL)

Last Closing Price: 33.41 (2026-11-19)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Castle Biosciences, Inc. (CSTL) had Earnings per Share (EPS) (Diluted) of $-0.13 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$102.89M
$-4.10M
$23.92M
$78.97M
$105.62M
$-2.73M
$-1.07M
$-3.80M
$-3.80M
$-4.10M
$-4.10M
$-4.10M
$-4.10M
$-2.73M
$1.10M
30.63M
30.63M
$-0.13
Earnings per Share (EPS) (Diluted)
$-0.13
Balance Sheet Financials
$356.86M
$111.46M
$222.55M
$579.41M
$67.61M
$6.15M
$33.35M
$100.96M
$478.44M
$386.95M
$478.44M
30.77M
Cash Flow Statement Financials
$12.81M
$-46.49M
$-5.05M
$116.73M
$77.99M
$-38.73M
$32.60M
--
--
Fundamental Metrics & Ratios
5.28
--
--
0.01
0.02
76.75%
-2.65%
-2.65%
--
-3.70%
-3.98%
$-15.76M
--
--
--
0.18
2.30
1.97
45.57
-0.86%
-1.06%
-0.71%
-0.85%
$15.55
$-0.51
$0.42